Li-Chuan Chan

The University of Texas MD Anderson Cancer Center

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis”.

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Journal of Clinical Investigation(2021)10.1172/jci139434

N/A

7.4DataRank · unranked

314 citations

Seung-Oe Lim, Meisi Yan, Jennifer L. Hsu, Jun Yao, Yongkun Wei +12 more

Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function

Cancer Research(2022)10.1158/0008-5472.can-21-2300

N/A

1.3DataRank · unranked

47 citations

Yongkun Wei, Yu‐Yi Chu, Yintao Li, Jung-Mao Hsu, Zhou Jiang +11 more

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.101817

N/A

0.815DataRank · unranked

21 citations

Li-Chuan Chan, Ying‐Nai Wang, Yu‐Yi Chu, Chie‐Hong Wang, Heng‐Huan Lee +17 more

Pivotal roles for cancer cell–intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity

JCI Insight(2024)10.1172/jci.insight.178644

N/A

0.399DataRank · unranked

9 citations

Il‐Kyu Kim, Charu Arora, Liz Quinones-Ware, Nikhil Joshi, Noah Cheng +12 more

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02206-x

N/A

0.327DataRank · unranked

6 citations

Chunxiao Liu, Meisi Yan, Cong Chen, Yu Cheng, Yaohui Chen +20 more

592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.592

N/A

0DataRank · unranked

8 citations

Sunil Krishnan, Ren‐Chin Wu, Akash R. Boda, Arthur Liu, Michelle Winkler +29 more

Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex

Nature Cancer(2022)10.1038/s43018-022-00438-2

N/A

0DataRank · unranked

37 citations

Mei‐Kuang Chen, Yongkun Wei, Heng‐Huan Lee, Weiya Xia, Ying‐Nai Wang +21 more

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

Nature Communications(2021)10.1038/s41467-021-23075-2

N/A

0DataRank · unranked

31 citations

Ying‐Nai Wang, Wenhao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan +25 more

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

International Journal of Biological Sciences(2023)10.7150/ijbs.84592

N/A

0DataRank · unranked

38 citations

Heng‐Huan Lee, Zhou Jiang, Li-Chuan Chan, Gabriel N. Hortobágyi, Dihua Yu +2 more

Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma

Journal of Hepatology(2020)10.1016/j.jhep.2020.09.030

N/A

0DataRank · unranked

32 citations

Zhengyu Zha, Chenhao Zhou, Yeh Chen, Weiya Xia, Ying‐Nai Wang +14 more

Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity

Cancer Research(2020)10.1158/0008-5472.can-19-3133

N/A

0DataRank · unranked

174 citations

Chia-Wei Li, Ezra M. Chung, Ri‐Yao Yang, Yong‐Soo Kim, Andrew H Park +15 more